Biocon's partner firm launches diabetes product in Japan

In March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news